Publications for Per Rosenberg
Co-author map based on ISI articles 2007-

Journal Articles

Henrik Green, Peter Söderkvist, Per Rosenberg, Rajaa A Mirghani, Per Rymark, Elisabeth Avall Lundqvist and Curt Peterson
  Pharmacogenetic Studies of Paclitaxel in the Treatment of Ovarian Cancer
  Basic and clinical pharmacology and toxicology, 2009, 104(2), 130-137.
   Fulltext  PDF  
 Web of Science® Times Cited: 28

B. Sorbe, H. Andersson, K. Boman, Per Rosenberg and M. Kalling
  Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel - Long-term follow-up
  International Journal of Gynecological Cancer, 2008, 18(4), 803-808.

Henrik Green, Peter Söderkvist, Per Rosenberg, Grörgy Horvath and Curt Peterson
  ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel
  Journal of Pharmaceutical Sciences, 2008, 97(6), 2045-2048.
   Fulltext  PDF  
 Web of Science® Times Cited: 20

Henrik Green, Peter Söderkvist, Per Rosenberg, Rajaa A. Mirghani, Per Rymark, Elisabeth Åvall-Lundqvist and Curt Peterson
  Pharmacogenetics of Paclitaxel in the Treatment of Ovarian Cancer – a Pilot Study in Preparation of Individualized Chemotherapy
  Clinical Cancer Research, 2007, , .

Henrik Green, Peter Söderkvist, Per Rosenberg, Horvath György and Curt Peterson
  Letters to the Editor: ABCB1 2677>T/A Genotype and paclitaxel pharmacogenetics in ovarian cancer - Response
  Clinical Cancer Research, 2006, 12(13), 4127-4129.

Henrik Green, Peter Söderkvist, Per Rosenberg, György Horvath and Curt Peterson
  mdr-1 single nucleotide polymorphisms in ovarian cancer tissue – G2677T/A correlates with response to paclitaxel chemotherapy
  Clinical Cancer Research, 2006, 12(3 pt 1), 854-859.
   Fulltext  PDF  
 Web of Science® Times Cited: 81

Henrik Green, Per Rosenberg, Peter Söderkvist, György Horvath and Curt Peterson
  β-tubulin mutations in ovarian cancer using single strand conformation analysis – risk of false positive results from paraffin embedded tissues
  Cancer Letters, 2006, 236(1), 148-154.
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Ph.D. Theses

Henrik Green
  Pharmacogenetic Studies of Paclitaxel in Ovarian Cancer: focus on interindividual differences in pharmacodynamics and pharmacokinetics
  2007.


  Fulltext PDF